Related Experiment Video
Updated: Apr 21, 2026
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Ovarian cancer: diagnostic, biological and prognostic aspects
1Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway.
Abstract:
Ovarian cancer remains the most lethal gynecologic malignancy, owing to late detection, intrinsic and acquired chemoresistance and remarkable heterogeneity. Despite optimization of surgical and chemotherapy protocols and initiation of clinical trials incorporating targeted therapy, only modest gains have been achieved in prolonging survival in this cancer. This review provides an update of recent developments in our understanding of the etiology, origin, diagnosis, progression and treatment of this malignancy, with emphasis on clinically relevant genetic classification approaches. In the authors' opinion, focused effort directed at understanding the molecular make-up of recurrent and metastatic ovarian cancer, while keeping in mind the unique molecular character of each of its histological types, is central to our effort to improve patient outcome in this cancer.
Insights
Ovarian cancer is a deadly gynecologic malignancy due to late detection and chemoresistance. Understanding its molecular basis, especially in recurrent and metastatic forms, is key to improving patient outcomes.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Ovarian cancer is the leading cause of gynecologic cancer death.
- Late detection, chemoresistance, and heterogeneity contribute to poor prognosis.
- Current treatments offer modest survival benefits.
Purpose of the Study:
- To review recent advancements in understanding ovarian cancer.
- To emphasize clinically relevant genetic classifications.
- To highlight the importance of molecular characterization for improved patient outcomes.
Main Methods:
- Literature review of recent developments.
- Focus on etiology, origin, diagnosis, progression, and treatment.
- Emphasis on genetic classification and molecular profiling.
Main Results:
- Ovarian cancer's complexity necessitates a deeper understanding of its molecular underpinnings.
- Clinically relevant genetic classifications are emerging.
- Recurrent and metastatic disease present unique molecular challenges.
Conclusions:
- Improving ovarian cancer patient outcomes requires focused research on the molecular characteristics of recurrent and metastatic disease.
- Tailoring treatment based on histological type and molecular profile is crucial.
- Continued research into genetic classifications will aid therapeutic strategies.
More Related Videos
05:42Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
